GLP-1 receptor agonists, or glucagon-like peptide-1 receptor agonists, were first developed to help people with type 2 diabetes manage their blood sugar levels
Molecular mechanisms underlying some major common risk factors of stroke
Chromatin proteins are critical for prenatal development
The information on this page is for educational purposes only and is not a substitute for professional medical advice
Newborns (especially preterm) lack the ability to metabolize benzyl alcohol, leading to metabolic acidosis, respiratory distress, hypotension and (in reported cases) the often-fatal gasping syndrome. For this reason, only preservative-free sterile water (no benzyl alcohol) is used in pediatric or neonatal care
GLP1 receptor agonists have changed the way we treat type 2 diabetes and obesity, offering powerful glucose-lowering effects and sustained weight loss